Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Taubert to Retire as JNJ EVP, Cavanaugh to Take Over

Guavy AI Editorial Team
Instruments
JNJ
Share

Jennifer Taubert will retire as Executive Vice President and Worldwide Chairman of Johnson & Johnson's Innovative Medicine business on September 1, 2026. She has spent over 21 years at the company.

Taubert led the company's pharmaceutical business to grow to more than $60 billion in annual revenue under her leadership. Her tenure saw significant advancements in oncology, immunology, neuroscience, and cardiovascular disease treatment.

Tom Cavanaugh will succeed Taubert as EVP, Worldwide Chairman Innovative Medicine. He has nearly three decades of biopharmaceutical experience and a proven track record of growth.

More on Stocks

Stocks 4m ago

Microsoft's AI Sales Rely Heavily on Partnership with OpenAI

Stocks 7m ago

Trump Takes Aim at Big Oil Profits

Stocks 8m ago

Coca-Cola HBC Share Price Fizzes After Earnings Upgrade

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy